Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$361M |
| 2 |
CVS Health
CVS
|
+$180M |
| 3 |
Cigna
CI
|
+$158M |
| 4 |
Microsoft
MSFT
|
+$102M |
| 5 |
Amazon
AMZN
|
+$90M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$301M |
| 2 |
AET
Aetna Inc
AET
|
+$270M |
| 3 |
PX
Praxair Inc
PX
|
+$184M |
| 4 |
ANDV
Andeavor
ANDV
|
+$97.3M |
| 5 |
COL
Rockwell Collins
COL
|
+$89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.86% |
| 2 | Financials | 13.99% |
| 3 | Healthcare | 13.63% |
| 4 | Industrials | 10.39% |
| 5 | Consumer Discretionary | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUD
2026
DELISTED
Audacy, Inc.
AUD
| $3.9M | ﹤0.01% |
683,885
-2,870
| -0.4% | -$19.1K |
|
2027
OraSure Technologies
OSUR
$279M
| $3.9M | ﹤0.01% |
334,240
+311
| +0.1% | +$4.13K |
|
2028
Mesa Laboratories
MLAB
$564M
| $3.9M | ﹤0.01% |
18,717
-114
| -0.6% | -$22.2K |
|
2029
Tredegar Corp
TG
$265M
| $3.88M | ﹤0.01% |
244,897
+20,432
| +9% | +$365K |
|
|
NEX
2030
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $3.88M | ﹤0.01% |
474,702
-8,698
| -2% | -$97.1K |
|
2031
Allogene Therapeutics
ALLO
$649M
| $3.88M | ﹤0.01% |
+144,127
| New | +$3.83M |
|
2032
Elanco Animal Health
ELAN
$13.2B
| $3.88M | ﹤0.01% |
+122,995
| New | +$4.03M |
|
2033
Triumph Financial Inc
TFIN
$1.81B
| $3.86M | ﹤0.01% |
129,905
-498
| -0.4% | -$17.6K |
|
2034
Community Health Systems
CYH
$393M
| $3.86M | ﹤0.01% |
1,367,951
-78,873
| -5% | -$271K |
|
|
FARO
2035
DELISTED
Faro Technologies
FARO
| $3.85M | ﹤0.01% |
94,804
+1,864
| +2% | +$90.4K |
|
|
ROCC
2036
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $3.85M | ﹤0.01% |
71,160
-11,912
| -14% | -$776K |
|
|
SINA
2037
DELISTED
Sina Corp
SINA
| $3.84M | ﹤0.01% |
71,630
+3,990
| +6% | +$246K |
|
2038
Amphastar Pharmaceuticals
AMPH
$879M
| $3.83M | ﹤0.01% |
192,656
-2,276
| -1% | -$44.9K |
|
2039
Novavax
NVAX
$1.2B
| $3.83M | ﹤0.01% |
104,171
-4,464
| -4% | -$173K |
|
|
NXRT
2040
NexPoint Residential Trust
NXRT
$666M
| $3.83M | ﹤0.01% |
109,285
+5,529
| +5% | +$192K |
|
2041
Stock Yards Bancorp
SYBT
$2.64B
| $3.83M | ﹤0.01% |
116,760
-708
| -0.6% | -$22.6K |
|
2042
Axogen
AXGN
$2.27B
| $3.82M | ﹤0.01% |
187,131
+3,190
| +2% | +$99.8K |
|
|
BMTC
2043
DELISTED
Bryn Mawr Bank Corp
BMTC
| $3.82M | ﹤0.01% |
111,075
-815
| -0.7% | -$32.2K |
|
2044
Garrett Motion
GTX
$5.81B
| $3.82M | ﹤0.01% |
+309,513
| New | +$4.21M |
|
|
LGF.A
2045
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $3.82M | ﹤0.01% |
237,122
+9,657
| +4% | +$187K |
|
|
TBRG
2046
DELISTED
TruBridge
TBRG
| $3.8M | ﹤0.01% |
151,285
-11,900
| -7% | -$310K |
|
2047
Arbor Realty Trust
ABR
$964M
| $3.77M | ﹤0.01% |
374,338
+33,023
| +10% | +$384K |
|
|
AUO
2048
DELISTED
AU Optronics Corp
AUO
| $3.77M | ﹤0.01% |
955,645
-139
| -0% | -$554 |
|
2049
Forum Energy Technologies
FET
$708M
| $3.76M | ﹤0.01% |
45,533
+4,358
| +11% | +$658K |
|
2050
Wave Life Sciences
WVE
$1.09B
| $3.75M | ﹤0.01% |
89,177
-1,269
| -1% | -$56.4K |
|
Similar funds
Charles Schwab's Q4 2018 Portfolio in Review
As of Q4 2018, Charles Schwab held 3,199 positions worth $131B, down 13% from $150B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q4 2018: portfolio turnover was 3.8%. Charles Schwab opened 67 new positions and exited 53, leaving the 3,199-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2018 buy was Linde: 2,286,208 shares worth $357M.
- Charles Schwab added most to CVS Health in Q4 2018, an estimated $180M increase.
- Charles Schwab's biggest Q4 2018 reduction was Qualcomm, cutting an estimated $42.7M.
- Charles Schwab fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $301M.
- Charles Schwab's ten largest holdings make up 15% of its $131B portfolio in Q4 2018.
- Charles Schwab opened 67 new positions and closed 53 in Q4 2018.
- Charles Schwab's portfolio value fell 13% quarter-over-quarter to $131B.
Based on Charles Schwab's 13F filing for Q4 2018, filed 14 Feb 2019.